Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3Prostatic Neoplasms 2mCRPC 1Triple Negative Breast Neoplasms 1Small Cell Lung Carcinoma 1Recurrence 1Pheochromocytoma 1Paraganglioma 1Ovarian Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Leukemia 1Extensive Stage Lung Small Cell Carcinoma 1Endometrial Neoplasms 1

Interventions

atezolizumab 2talazoparib 1Specimen Handling 1Magnetic Resonance Spectroscopy 1LB100 1Etoposide 1Carboplatin 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Extensive Stage Lung Small Cell Carcinoma × talazoparib × Clear all
NCT04334941 2026-06-05

Testing Maintenance Therapy for Small Cell Lung Cancer in Patients With SLFN11 Positive Biomarker

National Cancer Institute (NCI)

Phase 2 Active not recruiting
103 enrolled

Extensive Stage Lung Small Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡